Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes.
Am J Hematol
; 96(4): E111-E114, 2021 04 01.
Article
in En
| MEDLINE
| ID: mdl-33448430
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Erythrocyte Transfusion
/
Immunologic Factors
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos